Archive for December 2023
AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
Cosa Mesa, Calif., December 11, 2023 (GlobeNewswire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced completion of their first trial administering AIV001 (axitinib) to patients diagnosed with basal cell…
Read MoreAiViva BioPharma Appoints Les Kaplan, PhD, to the Board of Directors
AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors Costa Mesa, Calif., September 18, 2023 (GLOBENEWSWIRE) – AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies…
Read More